Pillstats
Rx only · Suspension · Respiratory (Inhalation)

Budesonide

Brands: Pulmicort Respules · Budesonide

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US23 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)19831
US makers11 labelers
Packages27
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 17 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.21$2.41$3.62$4.83Jun 2025Apr 2026Jul 2026
$2.060
Latest avg · Jul 22, 2026
-51%
Since Jun 18, 2025
11
Active US suppliers
37%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

63K125K188K251K2025 Q12025 Q22025 Q32025 Q42026 Q1
218K
Rx · 2026 Q1
20.2M
Units dispensed
+16%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Teva Pharmaceuticals USA, Inc.unknown7SUPPLYING
Sandoz Incunknown3SUPPLYING
A-S Medication Solutionsunknown3SUPPLYING
AstraZeneca Pharmaceuticals LPunknown3SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown3SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown2SUPPLYING
Chartwell RX, LLCunknown2SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
Preferred Pharmaceuticals Inc.unknown1SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 29, 2026
    RECALLRecall (Class II): Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 po…

    Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide within the United States

  • Jan 11, 2013
    RECALLRecall (Class III): PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton) Budesonide Inhalation Suspension NDC: 0186-1989-04

    Does Not Meet Monograph: Budesonide may be slightly above or below the specification range. — Recalling firm: AstraZeneca LP — Nationwide

  • Jan 11, 2013
    RECALLRecall (Class III): PULMICORT RESPULES 0.25 mg/2 ml Budesonide Inhalation Suspension (30 ampules/carton) NDC: 0186-1988-04

    Does Not Meet Monograph: Budesonide may be slightly above or below the specification range. — Recalling firm: AstraZeneca LP — Nationwide